Arcoma AB (SE:ARCOMA)

:ARCOMA

ARCOMA

Arcoma AB

RESEARCH TOOLSreports

Want to see SE:ARCOMA full AI Analyst Report?

Arcoma AB (ARCOMA) Price & Analysis

0 Followers

ARCOMA Stock Chart & Stats

kr7.20

-kr0.40(-3.79%)

At close: Mar 06 4:00 PM EST

kr7.20

-kr0.40(-3.79%)

Day’s Range― - ―

52-Week Rangekr6.16 - kr11.00

Previous CloseN/A

Volume10.05K

Average Volume (3M)22.73K

Market Cap

kr121.91M

Enterprise Valuekr92.55M

Total Cash (Recent Filing)kr33.94M

Total Debt (Recent Filing)kr0.00

Price to Earnings (P/E)32.1

Beta0.17

Next Earnings

Aug 20, 2026

EPS Estimate

0.14

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.26

Shares Outstanding14,308,510

10 Day Avg. Volume31,356

30 Day Avg. Volume22,732

Financial Highlights & Ratios

PEG Ratio-0.35

Price to Book (P/B)1.41

Price to Sales (P/S)0.80

P/FCF Ratio5.68

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.63

Revenue Forecast (FY)kr137.00M

Bulls Say, Bears Say

Bulls Say

Debt-free Balance SheetZero net debt and a solid equity base give Arcoma financial flexibility to fund R&D, service expansion or absorb cyclical weakness without refinancing risk. This durable strength reduces solvency risk and supports strategic investments and tender competitiveness over multiple quarters.

Strong Free Cash Flow GenerationSustained operating and free cash flow provide internal funding for product development, service network scale and working capital. Reliable cash conversion supports reinvestment in aftermarket capabilities that create recurring revenue and underpins medium-term resilience.

Recurring Service-driven Business ModelA hardware plus recurring service model creates an installed base that yields predictable aftermarket revenue and higher customer stickiness. Durable service income cushions equipment sales cyclicality and supports margin durability over multiple reporting periods.

Bears Say

Negative Revenue TrendsMaterial negative revenue growth weakens operating leverage and raises the burden on fixed R&D and service costs. If sales volumes do not stabilize, margin pressure and slower installed‑base expansion could constrain medium‑term organic growth and reinvestment capacity.

Volatile Margins And Earnings ConsistencyLarge swings in gross margin and uneven profitability reduce earnings predictability and complicate long‑range planning. Persistent volatility can signal pricing pressure, product mix swings or cost instability, undermining sustainable margin expansion over the next several quarters.

Limited Scale And ResourcesA very small headcount limits global sales, manufacturing scale and after‑sales coverage versus larger device makers. Scaling commercial reach and service infrastructure will require sustained investment and may slow wins in larger tenders and enterprise hospital contracts.

ARCOMA FAQ

What was Arcoma AB’s price range in the past 12 months?

Arcoma AB lowest stock price was kr6.16 and its highest was kr11.00 in the past 12 months.

What is Arcoma AB’s market cap?

Arcoma AB’s market cap is kr121.91M.

When is Arcoma AB’s upcoming earnings report date?

Arcoma AB’s upcoming earnings report date is Aug 20, 2026 which is in 67 days.

How were Arcoma AB’s earnings last quarter?

Arcoma AB released its earnings results on Apr 23, 2026. The company reported kr0.06 earnings per share for the quarter, missing the consensus estimate of kr0.18 by -kr0.12.

Is Arcoma AB overvalued?

According to Wall Street analysts Arcoma AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Arcoma AB pay dividends?

Arcoma AB does not currently pay dividends.

What is Arcoma AB’s EPS estimate?

Arcoma AB’s EPS estimate is 0.14.

How many shares outstanding does Arcoma AB have?

Arcoma AB has 14,308,510 shares outstanding.

What happened to Arcoma AB’s price movement after its last earnings report?

Arcoma AB reported an EPS of kr0.06 in its last earnings report, missing expectations of kr0.18. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Arcoma AB?

Currently, no hedge funds are holding shares in SE:ARCOMA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Arcoma AB

Arcoma AB is a global provider that designs, manufactures, and supplies cutting-edge radiology solutions. Their product line features advanced digital x-ray and radiography systems. These versatile systems are suitable for a wide array of radiographic applications and are utilized across various clinical environments, including general practice, musculoskeletal, thoracic, pediatric, and trauma/resuscitation units. The company distributes its products through a network of OEM partners. Arcoma AB was founded in 1990 and is headquartered in Växjö, Sweden.